In the subsequent clinical studies, IgM deposition independently associated with worse renal outcomes in patients with various glomerular diseases, including FSGS, IgA nephropathy (IgAN), and diabetic nephropathy (DN) [7–9]. The gene discussed is CD40LG; the disease is focal segmental glomerulosclerosis.